Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Bristol-Myers: A $44 Billion High-Yield Stock That Could Be in Trouble
Seeking Alpha
Thursday, March 24, 2011 - 9:19am
tags:
Bristol-Myers Squibb
GSK won’t pursue Avodart for prostate cancer
Bizjournals.com
Thursday, March 24, 2011 - 9:18am
tags:
prostate cancer, GSK, Avodart
Health-Care Overhaul Law Has Tumultuous First Year
WSJ Online
Wednesday, March 23, 2011 - 11:20am
tags:
healthcare reform
Payers may balk at Makena pricing, KV says
Fierce Pharma
Wednesday, March 23, 2011 - 11:15am
tags:
Makena, KV Pharmaceutical, drug pricing, premature birth
Omeros' eye surgery drug meets midstage study goals
Yahoo/AP
Wednesday, March 23, 2011 - 11:13am
tags:
Omeros, cataracts
J&J Faces $360M Penalty Over Risperdal Marketing
Pharmalot
Wednesday, March 23, 2011 - 10:34am
tags:
Risperdal, JNJ, Ortho-McNeil-Janssen
Amarin Example Shows Common Sense Is Crucial in Navigating Biotech Sector Volatility
Seeking Alpha
Wednesday, March 23, 2011 - 10:33am
tags:
Amarin, BioDelivery Sciences, Dendreon, Human Genome Sciences, MannKind, Titan, Vanda
What Biotech Wants From Big Pharma Partners: Survey Says!?
InVivo
Wednesday, March 23, 2011 - 10:29am
tags:
Big Pharma, biotech, Roche, Merck, GSK, Novartis, Pfizer, Eli Lilly
Gilead HIV drug meets study goal
Yahoo/AP
Wednesday, March 23, 2011 - 10:28am
tags:
Gilead Sciences, HIV, elvitegravir
Novartis must wait longer for FDA lung drug decision
Reuters
Wednesday, March 23, 2011 - 9:38am
tags:
FDA, COPD, Novartis, QAB149
Good News for ViroPharma Drug
Yahoo/Zacks.com
Wednesday, March 23, 2011 - 9:37am
tags:
ViroPharma, Cinryze, hereditary angiodema
Xoma Says its Diabetes Drug Failed to Lower Blood Sugar
Bloomberg
Wednesday, March 23, 2011 - 9:36am
tags:
diabetes, Xoma, XOMA 052
Pozen inks deal with J&J company for migraine drug
Yahoo/AP
Wednesday, March 23, 2011 - 9:34am
tags:
Pozen, JNJ, migraines, Cilag GmbH, MT-400
InSite cataract drug trial results could target market leader
Bizjournals.com
Tuesday, March 22, 2011 - 10:14pm
tags:
InSite Vision, cataracts, Xibrom, Ista, ISV-303
Failure of Sanofi, Merck Animal-Health Merger May Trigger Deals
Bloomberg
Tuesday, March 22, 2011 - 10:12pm
tags:
animal health, Merck, Sanofi, M&A, Novartis, Bayer
Pharmas in the Doghouse
Motley Fool
Tuesday, March 22, 2011 - 10:06pm
tags:
Merck, Sanofi, Pfizer, Genzyme, Novartis, Eli Lilly, JNJ
Bristol Myers paid new CEO $10.9 million
Yahoo/AP
Tuesday, March 22, 2011 - 10:05pm
tags:
Pharma CEOs, executive pay, Bristol-Myers Squibb, Lamberto Andreotti
Pozen files motion to stop generic Treximet
Bizjournals.com
Tuesday, March 22, 2011 - 11:28am
tags:
generics, Treximet, Pozen
Novartis’s $48,000 Pill Spurs U.S. Price Increases for MS Drugs
Bloomberg
Tuesday, March 22, 2011 - 11:07am
tags:
Novartis, Gilenya, MS, multiple sclerosis, Teva Pharmaceuticals, Biogen Idec, Roche
Amgen in deal with Tesaro
Bizjournals.com
Tuesday, March 22, 2011 - 11:04am
tags:
Amgen, Tesaro, oncology

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.